Search Results

There are 16560 results for: content related to: Changes in bone biomarker concentrations and musculoskeletal symptoms among breast cancer patients initiating aromatase inhibitor therapy and women without a history of cancer

  1. You have free access to this content
    Aromatase Inhibitor Associated Musculoskeletal Symptoms are associated with Reduced Physical Activity among Breast Cancer Survivors

    The Breast Journal

    Volume 20, Issue 1, January/February 2014, Pages: 22–28, Justin C. Brown, Jun J. Mao, Carrie Stricker, Wei-Ting Hwang, Kay-See Tan and Kathryn H. Schmitz

    Article first published online : 25 OCT 2013, DOI: 10.1111/tbj.12202

  2. Comparison of Changes in the Lipid Profile of Postmenopausal Women With Early Stage Breast Cancer Treated With Exemestane or Letrozole

    The Journal of Clinical Pharmacology

    Volume 52, Issue 12, December 2012, Pages: 1852–1860, Dr Lauren Nicole Bell, Ms Anne Thi Phuong Nguyen, Dr Lang Li, Dr Zeruesenay Desta, Dr N. Lynn Henry, Dr Daniel F. Hayes, Dr Antonio C. Wolff, Dr Vered Stearns, Dr Anna Maria Storniolo and Dr David A. Flockhart

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270011424153

  3. You have full text access to this OnlineOpen article
    A prospective study of aromatase inhibitor-associated musculoskeletal symptoms and abnormalities on serial high-resolution wrist ultrasonography

    Cancer

    Volume 116, Issue 18, 15 September 2010, Pages: 4360–4367, N. Lynn Henry, Jon A. Jacobson, Mousumi Banerjee, Jill Hayden, Jeffrey B. Smerage, Catherine Van Poznak, Anna Maria Storniolo, Vered Stearns and Daniel F. Hayes

    Article first published online : 19 AUG 2010, DOI: 10.1002/cncr.25385

  4. Effects of aromatase inhibitors and body mass index on steroid hormone levels in women with early and advanced breast cancer

    British Journal of Surgery

    K. M. Elliott, J. Dent, F. Z. Stanczyk, L. Woodley, R. C. Coombes, A. Purohit and C. Palmieri

    Article first published online : 31 MAR 2014, DOI: 10.1002/bjs.9477

  5. You have full text access to this OnlineOpen article
    Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer

    Cancer

    Volume 118, Issue 1, 1 January 2012, Pages: 241–247, Antonio Llombart-Cussac, Amparo Ruiz, Antonio Antón, Agustí Barnadas, Silvia Antolín, José E. Alés-Martínez, Isabel Álvarez, Raquel Andrés, José A. García Saenz, Juan Lao, Eva Carrasco, Carmen Cámara, Isabel Casas and Miguel Martín

    Article first published online : 29 JUN 2011, DOI: 10.1002/cncr.26299

  6. Enhanced bioavailability of exemestane via proliposomes based transdermal delivery

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 8, August 2011, Pages: 3208–3222, Raju Jukanti, Sruthi Sheela, Suresh Bandari and Prabhakar R. Veerareddy

    Article first published online : 14 MAR 2011, DOI: 10.1002/jps.22542

  7. You have free access to this content
    A prospective model of care for breast cancer rehabilitation: Bone health and arthralgias

    Cancer

    Volume 118, Issue S8, 15 April 2012, Pages: 2288–2299, Kerri M. Winters-Stone, Anna L. Schwartz, Sandra C. Hayes, Carol J. Fabian and Kristin L. Campbell

    Article first published online : 6 APR 2012, DOI: 10.1002/cncr.27465

  8. You have full text access to this OnlineOpen article
    A woman's heart

    Cancer

    Volume 115, Issue 9, 1 May 2009, Pages: 1813–1826, Michael S. Ewer and Stefan Glück

    Article first published online : 20 FEB 2009, DOI: 10.1002/cncr.24219

  9. You have full text access to this OnlineOpen article
    Cost-Effectiveness of Switching to Exemestane after 2 to 3 Years of Therapy with Tamoxifen in Postmenopausal Women with Early-Stage Breast Cancer

    Value in Health

    Volume 10, Issue 5, September/October 2007, Pages: 367–376, David Thompson, Douglas C. A. Taylor, Eduardo L. Montoya, Eric P. Winer, Stephen E. Jones and Milton C. Weinstein

    Article first published online : 16 JUN 2007, DOI: 10.1111/j.1524-4733.2007.00190.x

  10. When to start an aromatase inhibitor: Now or later?

    Journal of Surgical Oncology

    Volume 103, Issue 7, 1 June 2011, Pages: 730–738, Julie C. Doughty

    Article first published online : 24 FEB 2011, DOI: 10.1002/jso.21801

  11. Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women

    Intervention Review

    The Cochrane Library

    Lorna Gibson, David Lawrence, Claire Dawson and Judith Bliss

    Published Online : 7 OCT 2009, DOI: 10.1002/14651858.CD003370.pub3

  12. You have full text access to this OnlineOpen article
    Cost-effectiveness of switching to exemestane versus continued tamoxifen as adjuvant therapy for postmenopausal women with primary breast cancer

    Cancer

    Volume 110, Issue 3, 1 August 2007, Pages: 499–508, Nancy A. Risebrough, Shailendra Verma, Maureen Trudeau and Nicole Mittmann

    Article first published online : 25 JUN 2007, DOI: 10.1002/cncr.22824

  13. You have full text access to this OnlineOpen article
    A predictive model for exemestane pharmacokinetics/pharmacodynamics incorporating the effect of food and formulation

    British Journal of Clinical Pharmacology

    Volume 59, Issue 3, March 2005, Pages: 355–364, Marta Valle, Enrico Di Salle, Maria Gabriella Jannuzzo, Italo Poggesi, Maurizio Rocchetti, Riccardo Spinelli and Davide Verotta

    Article first published online : 9 FEB 2005, DOI: 10.1111/j.1365-2125.2005.02335.x

  14. Patient-reported outcomes in women with breast cancer enrolled in a dual-center, double-blind, randomized controlled trial assessing the effect of acupuncture in reducing aromatase inhibitor-induced musculoskeletal symptoms

    Cancer

    Volume 120, Issue 3, 1 February 2014, Pages: 381–389, Ting Bao, Ling Cai, Claire Snyder, Kelly Betts, Karineh Tarpinian, Jeff Gould, Stacie Jeter, Michelle Medeiros, Saranya Chumsri, Aditya Bardia, Ming Tan, Harvinder Singh, Katherin H. R. Tkaczuk and Vered Stearns

    Article first published online : 23 DEC 2013, DOI: 10.1002/cncr.28352

  15. Phase 3 Trials of Aromatase Inhibitors for Breast Cancer Prevention

    Annals of the New York Academy of Sciences

    Volume 1155, Issue 1, February 2009, Pages: 141–161, Barbara K. Dunn and Anne Ryan

    Article first published online : 26 FEB 2009, DOI: 10.1111/j.1749-6632.2009.03688.x

  16. Systematic Review of Bone Health in Older Women Treated with Aromatase Inhibitors for Early-Stage Breast Cancer

    Journal of the American Geriatrics Society

    Volume 60, Issue 9, September 2012, Pages: 1761–1767, Taryn Becker, Lorraine Lipscombe, Steven Narod, Christine Simmons, Geoffrey M. Anderson and Paula A. Rochon

    Article first published online : 17 SEP 2012, DOI: 10.1111/j.1532-5415.2012.04107.x

  17. Adjuvant therapy for postmenopausal ER-positive breast cancer. Why tamoxifen still has a future? The Leuven point of view

    International Journal of Gynecological Cancer

    Volume 16, Issue s2, September 2006, Pages: 505–510, P. NEVEN, R. PARIDAENS, F. AMANT, H. WILDIERS, P. BERTELOOT, K. LEUNEN, A. SMEETS, C. WELTENS, W. Van Den BOGAERT, E. Van LIMBERGEN, M.R. CHRISTIAENS and I. VERGOTE

    Article first published online : 26 SEP 2006, DOI: 10.1111/j.1525-1438.2006.00682.x

  18. Impaired reproduction in adult male, but not female, rats following juvenile treatment with the aromatase inhibitor, exemestane

    Birth Defects Research Part B: Developmental and Reproductive Toxicology

    Volume 92, Issue 4, August 2011, Pages: 304–313, Gregg D. Cappon, Robert E. Chapin, Mark E. Hurtt, Michael P. Wajnrajch and Leigh Ann Burns-Naas

    Article first published online : 15 JUN 2011, DOI: 10.1002/bdrb.20307

  19. Postmenopausal Women with DCIS Post-Mastectomy: A Potential Role for Aromatase Inhibitors

    The Breast Journal

    Volume 18, Issue 4, July/August 2012, Pages: 299–302, Rowan T. Chlebowski and Nananda Col

    Article first published online : 11 JUN 2012, DOI: 10.1111/j.1524-4741.2012.01267.x

  20. You have full text access to this OnlineOpen article
    An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane

    Cancer

    Volume 95, Issue 9, 1 November 2002, Pages: 2006–2016, Aman U. Buzdar, John F. R. Robertson, Wolfgang Eiermann and Jean-Marc Nabholtz

    Article first published online : 25 OCT 2002, DOI: 10.1002/cncr.10908